Doloromics is a leading-edge company focused on revolutionizing chronic pain management through precision medicine. We possess the most extensive multi-omic database of human sensory tissue, enabling us to create a detailed molecular map of pain-specific therapeutic targets via our proprietary Nociceptive Cartography. Our team, endowed with profound expertise in neuropharmacology, pain biology, and pharmaceutical development, is committed to discovering and developing safer, more effective analgesics. By addressing the root causes of pain across diverse chronic conditions, we aim to deliver personalized medications. Our innovative approach is supported by the DOLOReS platform, a state-of-the-art discovery engine that begins with human disease tissue analysis to uncover and validate pivotal pain drivers. At Doloromics, we're on a revolutionary mission to alleviate human suffering by transforming the pain treatment paradigm, ensuring patients receive the most targeted, effective care.